Research Cancer Biomarkers & Therapeutics
- Active Research
- Our Centers
- Labs & Facilities
A Wealth of Research Projects
Nemours supports many Children’s Oncology Group (COG) clinical trials and investigator-initiated studies, with collaboration among our hematology/oncology specialists and researchers. Across all of our sites, we’re currently involved in approximately 96 COG and 25 non-COG studies and more than 90 industry-sponsored clinical trials. We also conduct additional studies in our research labs.
Most of our patients participate in clinical trials of one type or other — in 2011 and 2012, for example, we enrolled 60 percent of our new cancer patients in clinical trials. We also maintain research affiliations with National Cancer Institute-designated cancer centers, including the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia and the Helen F. Graham Cancer Center at ChristianaCare Health System in Newark, Del.
Other research partnerships include the:
- Cancer Trials Support Unit (CTSU)
- Children’s Oncology Group (COG)
- Sarcoma Alliance for Research through Collaboration (SARC)
- Mayo Clinic Cancer Center
- Suncoast Research Base (formerly the Moffitt Research Base)
Center of Excellence
The Nemours Center for Cancer and Blood Disorders (NCCBD) works to maximize Nemours’ resources across all of our locations. Our mission is to develop and implement a coordinated research strategy for cancer and blood disorders, enable quality clinical and research efforts, and develop educational resources and programs for our staff across all disciplines. We operate focused programs in pediatric cancer research (the Nemours Center for Childhood Cancer Research) and sickle cell disease (the Comprehensive Sickle Cell Research Program).
Our care has been regularly named among the nation’s best in pediatric cancer care by U.S. News and World Report. We believe that our rigorous approach to research, combined with our excellent clinical care, is a big reason why.
We’ve been a full member of the Children’s Oncology Group (COG) since it formed in 2000, a member of the Sarcoma Alliance for Research through Collaboration (SARC), and a founding member of the Pediatric Preclinical Testing Program (PPTP). In addition, Nemours locations in Delaware and Florida have received accreditation from the internationally-recognized Foundation for the Accreditation of Cellular Therapy (FACT). This group of leading experts recognizes our work in the field of cellular therapy transplantation.
Labs & Facilities
At Nemours, pediatric cancer research is very much a group effort. Our physicians not only deliver care, they’re actively involved with research and in constant contact with the research scientists in our labs.
High-Throughput Screening and Drug Discovery Lab
With the use of robotic equipment, Nemours researchers at our high-throughput lab (based at Nemours Children’s Hospital, Delaware) are able to screen thousands of potential drugs in a short time (this is called, “high-throughput”). Currently, we’re working to identify more effective treatments for childhood leukemia.